Ying-Yong Zhao

Natural product therapy in diabetic kidney disease: emerging multiomics-mediated signalling pathway and molecular target

Diabetic kidney disease (DKD) is one of the most common microvascular complications of diabetes, with high mortality and morbidity, and is a major cause of progression to end-stage renal disease (ESRD). Although inhibitors or blockers of renin-angiotensin system blockers have a beneficial effect on the treatment of DKD...